These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25467593)

  • 1. Is Canada patent deal obstructing Ebola vaccine development?
    Attaran A; Nickerson JW
    Lancet; 2014 Nov; 384(9958):e61. PubMed ID: 25467593
    [No Abstract]   [Full Text] [Related]  

  • 2. Ebola vaccine will be made available for emergency use.
    Gulland A
    BMJ; 2016 Jan; 532():i386. PubMed ID: 26801975
    [No Abstract]   [Full Text] [Related]  

  • 3. New Ebola vaccine trial is underway.
    Perspect Public Health; 2015 Mar; 135(2):59. PubMed ID: 25759318
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal preparedness and Ebola vaccines.
    Monahan J; Halabi S
    Lancet; 2015 Jul; 386(9991):338-9. PubMed ID: 26227464
    [No Abstract]   [Full Text] [Related]  

  • 5. Ebola drug trials set to begin amid crisis.
    Butler D
    Nature; 2014 Sep; 513(7516):13-4. PubMed ID: 25186878
    [No Abstract]   [Full Text] [Related]  

  • 6. US provides immunity from legal claims related to three Ebola vaccines.
    McCarthy M
    BMJ; 2014 Dec; 349():g7608. PubMed ID: 25499701
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 8. Infectious diseases. The Ebola vaccine underdog.
    Link C; Cohen J
    Science; 2014 Oct; 346(6209):534. PubMed ID: 25359944
    [No Abstract]   [Full Text] [Related]  

  • 9. Ebola vaccines line up while industry calls for change.
    Petherick A
    Lancet; 2015 Oct; 386(10002):1434-5. PubMed ID: 26466032
    [No Abstract]   [Full Text] [Related]  

  • 10. Amendment to UK Patent Act provides further exception to patent infringement.
    Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):349. PubMed ID: 25291308
    [No Abstract]   [Full Text] [Related]  

  • 11. Public health: Behind a vaccine.
    Nelson B
    Nature; 2015 Apr; 520(7549):711-3. PubMed ID: 25932490
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious disease. Ebola vaccine: little and late.
    Cohen J
    Science; 2014 Sep; 345(6203):1441-2. PubMed ID: 25237082
    [No Abstract]   [Full Text] [Related]  

  • 13. War zone complicates roll-out of Ebola vaccine in latest outbreak.
    Maxmen A
    Nature; 2018 Aug; 560(7718):289-290. PubMed ID: 30108347
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory policy for research and development of vaccines for public health emergencies.
    Kieny MP; Rägo L
    Expert Rev Vaccines; 2016 Sep; 15(9):1075-7. PubMed ID: 27181597
    [No Abstract]   [Full Text] [Related]  

  • 15. Ebola vaccine and corporate responsibility.
    Friedman JH
    R I Med J (2013); 2015 Nov; 98(11):9-10. PubMed ID: 26517246
    [No Abstract]   [Full Text] [Related]  

  • 16. DRC getting ready to introduce a second Ebola vaccine.
    Burki T
    Lancet Infect Dis; 2019 Nov; 19(11):1174-1175. PubMed ID: 31657782
    [No Abstract]   [Full Text] [Related]  

  • 17. Ebola: an opportunity for a clinical trial?
    Arie S
    BMJ; 2014 Aug; 349():g4997. PubMed ID: 25098954
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials for Ebola vaccines staged in Africa, North America and Europe.
    Hum Vaccin Immunother; 2014; 10(12):3427-8. PubMed ID: 26052585
    [No Abstract]   [Full Text] [Related]  

  • 19. Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.
    Espeland EM; Tsai CW; Larsen J; Disbrow GL
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006275. PubMed ID: 29621257
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial of Ebola virus vaccine is due to start next week.
    Arie S
    BMJ; 2014 Sep; 349():g5562. PubMed ID: 25209382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.